Another factor in your choice of pizza
By AMERICAN SOCIETY FOR
NUTRITION
New research from a mouse study indicates that elenolic acid, a compound naturally occurring in olives, may reduce blood sugar levels and promote weight loss. This study could lead to the creation of affordable and safe natural products designed to help manage obesity and type 2 diabetes in humans.
The researchers found that after just one
week, obese mice with diabetes that were given oral elenolic acid weighed
significantly less and showed better blood sugar (glucose) regulation than
before treatment and compared to control obese mice not receiving elenolic
acid. The glucose-lowering effect was comparable with that of the injectable
diabetic medication liraglutide and better than metformin, one of the most
common oral medicines for type 2 diabetes.
“Lifestyle modifications and public health
measures have had limited impact on the rising prevalence of obesity, one of
the top risk factors for type 2 diabetes,” said research team leader Dongmin
Liu, PhD, a professor in the Department of Human Nutrition, Foods and Exercise
at Virginia Tech. “Available obesity drugs are ineffective in weight loss
maintenance, expensive, and/or carry potential long-term safety risks. Our goal
was to develop safer, cheaper, and more convenient multi-targeting agents that
can prevent the occurrence of metabolic disorders and type 2 diabetes.”
Hana Alkhalidy, PhD, a research scientist in Liu’s lab at Virginia Tech, presented the findings at NUTRITION 2024, the flagship annual meeting of the American Society for Nutrition held June 29–July 2 in Chicago.
Focus on
Bioactive Compounds
Liu’s research team focuses on discovering
bioactive compounds from natural products for diabetes management. Previously,
they looked for specific molecular targets for natural compounds in parts of
the body that actively help regulate metabolism, such as the pancreas, muscle,
fat tissues, and liver. However, since natural products typically have poor
bioavailability, they decided to see if they could instead target metabolic
hormone secretion in the gut to indirectly regulate metabolic function.
For the new work, the researchers began by
identifying natural compounds that act on L-cells, which contain two metabolic
hormones released during a meal. These hormones, called GLP-1 and PYY, work
together to promote satiety and prevent overeating while also controlling blood
sugar levels and metabolism. The screening process revealed that elenolic acid,
which is found in mature olives and extra virgin olive oil, can induce the
release of these hormones in the gut. They were able to make elenolic acid by breaking
down its precursor oleuropein, which is less expensive than extracting it
directly from olives.
Promising
Results in Mice
Tests of the compound in obese mice with
diabetes revealed that mice that received oral elenolic acid experienced
significant improvements in their metabolic health compared to obese control
mice. After four to five weeks of treatment, the mice showed a 10.7% reduction
in obesity as well as blood sugar levels and insulin sensitivity
that were comparable to those of healthy lean mice.
The elenolic acid also significantly reduced
food intake and promoted weight loss, which are associated with improved
circulating levels of PYY and GLP-1 and the downregulation of agouti-related
peptide in the hypothalamus. Agouti-related peptide is known to increase eating
and weight gain when overexpressed.
“Overall, the study showed that elenolic acid
from olives has promising effects on hormone release and metabolic health,
particularly in obese and diabetic conditions,” said Liu. “The compound seems
to mimic the physiological conditions of eating to directly promote gut
metabolic hormone secretion, which helps regulate energy balance and metabolic
health.”
According to the researchers, the
concentration of elenolic acid in olive oil or olives is very low, so the
benefits seen in this study would most likely not be gained from olive products
alone.
The research team is now working to
understand how this compound creates metabolic benefits by analyzing its
journey through the body to find out how it is absorbed, distributed,
metabolized, and excreted. This will also reveal insights into its safety for
future clinical trials.
Reference: “Identification of a Novel
Multi-target Bioactive Compound With Anti-obesity and Anti-diabetic Activities”
by Hana Alkhalid, Yao Wang, Elizabeth Gilbert and Dongmin Liu, 29 June
2024, NUTRITION 2024.